6Haq M,Harmer C.Thyroid cancer:an overview.Nucl Med Commum,2004,25:861-867.
7Thyroid Carcinoma Task Force.AACE/AAES medical/surgical guidelines for clinical practice:management of thyroid carcinoma.American Association of Clinical Endocrinologists.American College of Endocrinology.Endocr Pract,2001,7:202-220.
8Coli A,Bigotti G,Zucchetti F,et al.Galectin-3,a marker of well-differentiated thyroid carcinoma,is expressed in thyroid nodules with cytologic atypia.Histopathology,2002,40:80-87.
9Zidan J,Kassem S,Kuten A.Follicular carcinoma of the thyroid gland:prognostic factors,treatment,and survival.Am J Clin Oncol,2000,23:1-5.
10Haq M,Harmer C.Differentiated thyroid carcinoma with distant metastases at presentation:prognostic factors and outcome.Clin Endocrinol(Oxf),2005,63:87-93.
